151751-Najiba-Chargi

136 CHAPTER 7 15. Findlay M, White K, Lai M, Luo D, Bauer JD. The Association Between Computed Tomography–Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review. J Acad Nutr Diet . 2020;120(8):1330-1347.e8. doi:10.1016/j.jand.2020.03.021 16. Wong A, Zhu D, Kraus D, Tham T. Radiolog - ically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis. Laryngoscope . March 2020. doi:10.1002/ lary.28616 17. Swartz JE, Pothen AJ, Wegner I, et al. Feasibility of using head and neck CT im - aging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol . 2016;62:28-33. doi:10.1016/j.oraloncolo - gy.2016.09.006 18. Chargi N, Ansari E, Huiskamp LFJ, Bol G, de Bree R. Agreement between skeletal muscle mass measurements using computed to- mography imaging andmagnetic resonance imaging in head and neck cancer patients. Oral Oncol . 2019;99:104341. doi:10.1016/j. oraloncology.2019.06.022 19. Bril SI, Wendrich AW, Swartz JE, et al. In - terobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra. Eur Arch Oto-Rhino-Laryngology . 2019;276(4):1175-1182. doi:10.1007/s00405- 019-05307-w 20. Ansari E, Chargi N, van Gemert JTM, et al. Low skeletal muscle mass is a strong pre- dictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular reconstruction with a free fibula flap. Oral Oncol . 2020;101. doi:10.1016/j.oraloncology.2019.104530 21. Alwani MM, Jones AJ, Novinger LJ, et al. Impact of Sarcopenia on Out - comes of Autologous Head and Neck Free Tissue Reconstruction. J Recon- str Microsurg . 2020;36(5):369-378. doi:10.1055/s-0040-1701696 22. Jones AJ, Campiti VJ, Alwani M, et al. Low Skeletal Muscle Mass Predicts Discharge Disposition after Free Flap Reconstruc - tion in Head and Neck Cancer Patients. Int J Radiat Oncol . 2020;106(5):1166-1167. doi:10.1016/j.ijrobp.2019.11.161 23. Rier HN, Jager A, Sleijfer S, Maier AB, Levin M. The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. Oncologist . 2016;21(11):1396-1409. doi:10.1634/theon - cologist.2016-0066 24. Gré Goire V, Lefebvre J-L, Licitra L, Felip E. clinical practice guidelines Squamous cell carcinoma of the head and neck: EHNS-ES - MO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up On behalf of the EHNS-ESMO-ESTRO Guidelines Working Group*. Ann Oncol . 2010;21:184-186. doi:10.1093/annonc/ mdq185 25. Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutro - phil-to-lymphocyte ratio in breast cancer: A systematic review and meta-analysis. Breast Cancer Res . 2017;19(1). doi:10.1186/ s13058-016-0794-1 26. Haram A, Boland MR, Kelly ME, Bolger JC, Waldron RM, KerinMJ. The prognostic value of neutrophil-to-lymphocyte ratio in col- orectal cancer: A systematic review. J Surg Oncol . 2017;115(4):470-479. doi:10.1002/ jso.24523 27. Pirozzolo G, Gisbertz SS, Castoro C, van Berge Henegouwen MI, Scarpa M. Neutro - phil-to-lymphocyte ratio as prognostic marker in esophageal cancer: A system- atic review and meta-analysis. J Thorac Dis . 2019;11(7):3136-3145. doi:10.21037/ jtd.2019.07.30 28. Zhou Y, Wei Q, Fan J, Cheng S, Ding W, Hua Z. Prognostic role of the neutrophil-to-lym - phocyte ratio in pancreatic cancer: A me- ta-analysis containing 8252 patients. Clin Chim Acta . 2018;479:181-189. doi:10.1016/j. cca.2018.01.024